Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Durable complete response

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon May 31, 2023 12:37am

216 Views

Post# 35471656

RE:Durable complete response

Eoganacht wrote: We have a durable complete response of 33% and I think we are on track to achieve a 41% complete durable response 180 days from now.

Looks like it, and that would still include 12 undertreated patients. Results are getting better and better and once final data comes out without undertreated patients, I think we will see an extra 10% CR, plus some more IRt to CR conversion to end up around 50-55% Durable CR. IMHO, and at least in the mid 40's.

<< Previous

Bullboard Posts

Next >>

Two Canadian healthcare stocks to watch